The KRT20 Knockout Ca Ski Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Ca Ski human cervical carcinoma line, designed to disrupt the KRT20 gene. The targeted gene encodes keratin 20, a type I intermediate filament protein critical for maintaining cytoskeletal architecture in epithelial cells. The polyclonal format ensures a heterogeneous loss-of-function pool, minimizing clonal selection artifacts and enabling robust characterization of KRT20-dependent phenotypes. This system offers a versatile platform for dissecting keratin 20??s role in epithelial biology and HPV-associated oncogenesis.
Ca Ski cells, originally established from a cervical epidermoid carcinoma metastasis, harbor an integrated human papillomavirus type 16 (HPV16) genome and are a standard model for HPV-related cervical carcinogenesis. The cell line recapitulates essential features of squamous carcinoma biology, including viral oncogene-driven transformation and aberrant epithelial differentiation. Its HPV positivity makes it particularly relevant for contextualizing KRT20 function within viral-mediated oncogenic pathways.
At the molecular level, KRT20 forms obligate heterodimers with keratin 8 (KRT8), which are essential for epithelial intermediate filament network integrity. KRT20 expression is transcriptionally regulated by CDX2, HNF4A, GATA4, and retinoic acid signaling, placing it downstream of key differentiation and developmental cues. The protein interacts with desmosomal components desmoplakin and plakoglobin, thereby tethering intermediate filaments to cell?Ccell adhesion sites. Loss of KRT20 may consequently disrupt actin cytoskeleton organization, modulate ??-catenin/TCF/LEF-mediated Wnt signaling, and alter cell cycle progression through downstream adhesion-dependent effectors. This molecular framework integrates KRT20 into keratinocyte differentiation, Wnt, Notch, and cytokine-mediated pathways.
In the Ca Ski cervical carcinoma background, KRT20 knockout is expected to compromise cytoskeletal integrity, weaken desmosomal adhesion, and perturb epithelial differentiation programs frequently dysregulated in squamous cell carcinoma. Given the integrated HPV16 genome, this model enables exploration of potential crosstalk between viral oncoproteins and keratin network function. Thus, the polyclonal knockout cells serve as a valuable tool for dissecting how intermediate filament disruption influences HPV-driven carcinogenesis, invasion, and therapeutic response.
Research applications include mechanistic studies of cervical cancer cell biology, HPV-mediated oncogenesis, keratin cytoskeleton dynamics, and epithelial differentiation. The knockout cells are suited for drug screening targeting cytoskeletal or adhesion vulnerabilities, and for transcriptomic analyses via RNA-seq to uncover pathway alterations. Commonly employed assays include Western blotting and RT-qPCR for KRT20 expression, immunofluorescence for keratin network visualization, cell migration and invasion assays, proliferation measurements, and colony formation assays. For further technical details and ordering, please contact Ascent Research.
